Expanded evidence for frozen fecal microbiota transplantation for clostridium difficileinfection a fresh take

JAMA - Journal of the American Medical Association

Volumn 315, Issue 2, 2016, Pages 137-138

  Malani, Preeti N ^a   Rao, Krishna ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ABDOMINAL PAIN; BACTERIAL VIRULENCE; CANADA; CLOSTRIDIUM DIFFICILE INFECTION; CRYOPRESERVATION; DIARRHEA; EDITORIAL; FECAL MICROBIOTA TRANSPLANTATION; FEVER; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; INTESTINE FLORA; LEUKOCYTOSIS; MATERIALS HANDLING; MORTALITY; MULTICENTER STUDY (TOPIC); PEPTOCLOSTRIDIUM DIFFICILE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT INFECTION; THAWING; TREATMENT OUTCOME; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; MALE;

CLOSTRIDIUM DIFFICILE; CRYOPRESERVATION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMANS; MALE;

EID: 84954566539     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.18100     Document Type: Editorial

References (13)

1. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398-408.
2. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-834.
3. Abou Chakra CN, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One. 2014;9(6):e98400.
4. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53(10):994-1002.
5. Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet. 1983;2(8354):845.
6. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407-415.
7. Rao K, Safdar N. Fecal microbiota transplantation for the treatment of Clostridium difficile infection [published online September 7, 2015]. J Hosp Med. 2015. doi:10.1002/jhm.2449.
8. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):1772-1778.
9. Lee CH, Steiner T, Petrof EO, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. doi:10.1001/jama.2015.18098.
10. Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859-904.
11. US Food and Drug Administration (FDA). Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies. FDA website. http://www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/ucm361379.htm. Accessed December 13, 2015.
12. US Food and Drug Administration (FDA). Draft Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies. FDA website. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm387023.htm. Accessed December 13, 2015.
13. Magill SS, Edwards JR, Beldavs ZG, et al; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. JAMA. 2014;312(14):1438-1446.